Results 111 to 120 of about 29,324 (231)

Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate

, 2022
Marcelo Antônio de Oliveira, Gerliane Damázio da Silva, Michele Soares Tacchi Campos   +2 more
openalex   +1 more source

In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma [PDF]

, 2017
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Ingo Schmidt‐Wolf   +2 more
openalex   +1 more source

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database [PDF]

Qun Li, Wenya Shan, Shasha Wu
openalex   +1 more source

Simultaneous Quantitative Resolution of Atorvastatin Calcium and Fenofibrate in Pharmaceutical Preparation by Using Derivative Ratio Spectrophotometry and Chemometric Calibrations [PDF]

, 2007
Nagaraj, Kalamkar Vipul, Mashru Rajshree
openalex   +1 more source

Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis

, 2021
Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada   +2 more
openalex   +2 more sources

Improvement of myocardial lipid accumulation and prevention of PGC-1α induction by fenofibrate

, 2012
Ming‐Xi Zang
openalex   +2 more sources

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late‐Onset Hypogonadism and Atherogenic Dyslipidemia [PDF]

, 2015
Robert Krysiak, Wojciech Gilowski, Bogusław Okopień   +2 more
openalex   +1 more source

Fenofibrate shown to reduce progression of diabetic retinopathy [PDF]

Iskandar Idris
openalex   +1 more source

Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia

Cost Effectiveness and Resource Allocation
Background This study investigated the cost-effectiveness of using fenofibrate to treat type 2 diabetes in Australia. The financial burden of type 2 diabetes mellitus is estimated to surpass AUD10 billion, mainly due to the cost of diabetic complications
Hansoo Kim, Juntao Lyu, Vikrama Raja, Kyoo Kim   +3 more
doaj   +1 more source

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats [PDF]

, 2011
Astrid Kamilla Stunes, Irene Westbroek, Björn Gustafsson, Reidar Fossmark, J.H. Waarsing, Erik Fink Eriksen, Christiane Petzold, Janne E. Reseland, Unni Syversen   +8 more
openalex   +1 more source